Literature DB >> 30474699

The side and the location of the primary tumor does not affect the probability of lymph node invasion in patients with renal cell carcinoma.

Alessandro Nini1,2, Alessandro Larcher1,2, Walter Cazzaniga1,2, Paolo Dell'Oglio1,2, Francesco Cianflone1,2, Fabio Muttin1,2, Francesco Ripa1,2, Andrea Salonia1,2, Alberto Briganti1,2, Francesco Montorsi1,2, Roberto Bertini1,2, Umberto Capitanio3,4.   

Abstract

PURPOSE: To evaluate the role of side and location of the primary renal cell carcinoma (RCC) on the risk of lymph node invasion (LNI) and/or nodal progression (NP) during follow-up.
MATERIALS AND METHODS: We evaluated 2485 patients with unilateral RCC, surgically treated in a single tertiary care referral center. Outcomes were LNI at surgery and/or NP during follow-up. We studied if RCC side (left vs. right) and location (upper vs. middle vs. hilar vs. lower area vs. more than one area) affected the probability of LNI and/or NP at follow-up.
RESULTS: Overall, 43 and 15% of patients underwent lymph node dissection and had LNI at surgery, respectively. During follow-up, 2.2% of patients had NP. Higher rates of LNI and NP were observed for patients with primary tumor located in more than one anatomical kidney area relative to patients with tumor in a single area (upper 11% vs. middle 10% vs. hilar 0%, vs. lower 12% vs. more than one area 26%, p < 0.01). cM1, cN1, pT2/pT3/pT4 disease and Fuhrman grade 3/4 were independent predictors of the study outcome (all p ≤ 0.01). Neither the RCC side nor the location reached the independent predictor status (all p > 0.1).
CONCLUSIONS: Patients with single-side and more than one anatomical kidney area affected by RCC have higher rate of LNI at surgery and/or NP at follow-up. Neither side nor location of primary RCC tumor is related to the risk of harboring LNI at surgery and/or developing NP at follow-up.

Entities:  

Keywords:  Kidney cancer; Lymph node invasion; Metastases; Renal cancer

Mesh:

Year:  2018        PMID: 30474699     DOI: 10.1007/s00345-018-2573-3

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  14 in total

Review 1.  Renal cancer.

Authors:  Umberto Capitanio; Francesco Montorsi
Journal:  Lancet       Date:  2015-08-25       Impact factor: 79.321

2.  Sentinel node detection in renal cell carcinoma. A feasibility study for detection of tumour-draining lymph nodes.

Authors:  Amir M Sherif; Elisabeth Eriksson; Magnus Thörn; Janos Vasko; Katrine Riklund; Lars Ohberg; Börje J Ljungberg
Journal:  BJU Int       Date:  2011-08-24       Impact factor: 5.588

Review 3.  Lymphatic drainage in renal cell carcinoma: back to the basics.

Authors:  Riaz J Karmali; Hiroo Suami; Christopher G Wood; Jose A Karam
Journal:  BJU Int       Date:  2014-08-13       Impact factor: 5.588

4.  Follow-up for Renal Cell Carcinoma: Absence of Evidence and Beyond.

Authors:  Axel Bex
Journal:  Eur Urol Focus       Date:  2015-08-12

5.  Intraoperative sentinel node identification and sampling in clinically node-negative renal cell carcinoma: initial experience in 20 patients.

Authors:  A Bex; L Vermeeren; W Meinhardt; W Prevoo; S Horenblas; R A Valdés Olmos
Journal:  World J Urol       Date:  2010-11-25       Impact factor: 4.226

6.  Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma.

Authors:  Max Kates; Hugh J Lavery; Jonathan Brajtbord; David Samadi; Michael A Palese
Journal:  Ann Surg Oncol       Date:  2012-04-20       Impact factor: 5.344

7.  Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.

Authors:  Alain Ravaud; Robert J Motzer; Hardev S Pandha; Daniel J George; Allan J Pantuck; Anup Patel; Yen-Hwa Chang; Bernard Escudier; Frede Donskov; Ahmed Magheli; Giacomo Carteni; Brigitte Laguerre; Piotr Tomczak; Jan Breza; Paola Gerletti; Mariajose Lechuga; Xun Lin; Jean-Francois Martini; Krishnan Ramaswamy; Michelle Casey; Michael Staehler; Jean-Jacques Patard
Journal:  N Engl J Med       Date:  2016-10-09       Impact factor: 91.245

8.  Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.

Authors:  Umberto Capitanio; Claudio Jeldres; Jean-Jacques Patard; Paul Perrotte; Laurent Zini; Alexandre de La Taille; Vincenzo Ficarra; Luca Cindolo; Karim Bensalah; Walter Artibani; Jacques Tostain; Antoine Valeri; Richard Zigeuner; Arnaud Méjean; Jean Luc Descotes; Eric Lechevallier; Peter F Mulders; Herve Lang; Didier Jacqmin; Pierre I Karakiewicz
Journal:  BJU Int       Date:  2008-10-16       Impact factor: 5.588

9.  A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.

Authors:  Michael L Blute; Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke
Journal:  J Urol       Date:  2004-08       Impact factor: 7.450

Review 10.  The rationale and the role of lymph node dissection in renal cell carcinoma.

Authors:  Umberto Capitanio; Bradley C Leibovich
Journal:  World J Urol       Date:  2016-06-30       Impact factor: 4.226

View more
  1 in total

1.  PAPP-A functions as a tumor suppressor and is downregulated in renal cell carcinoma.

Authors:  Yanxin Lu; Shi Li; Tongyu Wang; Ximian Liao; Longyi Mao; Zesong Li
Journal:  FEBS Open Bio       Date:  2021-05-02       Impact factor: 2.693

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.